2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on mUC: Can Tumor Microenvironment Biomarkers Help Predict Which Patients May Derive Greater Benefit from Upfront Anti-PD-L1 Therapy With Atezolizumab?

214 views
August 13, 2020
Comments 0
Login to view comments. Click here to Login